Gilead Caught Between Making a Profit and Treating the World

(Bloomberg) -- Gilead Sciences Inc. may spend $1 billion on its breakthrough new treatment for Covid-19 this year alone, Chief Executive Officer Daniel O’Day said. How much revenue -- if any -- the...